Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05946941 · ClinicalTrials.gov registry record · Phase 3

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

A Phase 3 study of Sjögren's Syndrome, sponsored by Bristol-Myers Squibb.

Active
Registry status
Phase 3
Development phase
774
Enrollment target
20
Study locations

NCT05946941 is a Phase 3 study of Sjögren's Syndrome that is active but no longer recruiting, run by Bristol-Myers Squibb. The registered enrollment target is 774 participants, above the 315-participant average among 4 other Sjögren's Syndrome trials with a reported enrollment target (146% higher). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05946941, a Phase 3 study of Sjögren's Syndrome, is active but no longer recruiting, sponsored by Bristol-Myers Squibb.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
774 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Conditions Studied

Sjögren's Syndrome

Interventions

  • OTHER Placebo
  • DRUG Deucravacitinib

Study Locations (20)

California

  • Local Institution - 0228 - Fullerton
  • Local Institution - 0222 - La Palma
  • Local Institution - 0218 - San Francisco
  • Local Institution - 0203 - Santa Monica

Florida

  • Local Institution - 0049 - Clearwater
  • Local Institution - 0226 - Cooper City
  • Local Institution - 0223 - Sarasota

Georgia

  • Local Institution - 0140 - Augusta
  • Local Institution - 0229 - Lawrenceville

Louisiana

  • Local Institution - 0017 - Baton Rouge
  • Local Institution - 0125 - Monroe

Colorado

  • Local Institution - 0067 - Denver

Illinois

  • Local Institution - 0174 - Skokie

Kansas

  • Local Institution - 0016 - Kansas City

Maryland

  • Local Institution - 0187 - Baltimore

Trial Details

FieldValue
Enrollment Target 774 participants
Start Date 2023-09-11
Est. Completion 2028-11-16
Phase Phase 3

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05946941

The ClinicalTrials.gov registry entry for NCT05946941 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 774 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 315-participant average among 4 other Sjögren's Syndrome trials with a reported enrollment target (146% higher). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sjögren's Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05946941 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT05946941 about?

NCT05946941 is a clinical study titled "A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome". The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

What is the current status of trial NCT05946941?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 774 participants. The study started on 2023-09-11. Estimated completion is 2028-11-16.

What conditions does trial NCT05946941 study?

This clinical trial studies the following conditions: Sjögren's Syndrome.

What interventions are being tested in trial NCT05946941?

The interventions under investigation include: Placebo (OTHER), Deucravacitinib (DRUG).

Who is sponsoring clinical trial NCT05946941?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05946941 being conducted?

This trial has 20 study locations across California, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sjögren's Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sjögren's Syndrome

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.